Acrivon Therapeutics Inc (ACRV)
1.56
+3.89%
Acrivon Therapeutics Inc (ACRV) is currently trading at $1.56. This represents a gain of 3.89% from the previous session. With a market capitalization of $0.05B, ACRV is a key component of the Health Care sector. Investors looking to trade ACRV should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade ACRV commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Acrivon Therapeutics Inc (ACRV) shows a bullish trend. Analysts are watching the 1.58 level closely.
Fundamentals
Mkt Cap0.05B
P/E Ratio0.0000
Volume843,980
60-Day Technical Chart
Advanced Charting
Need more indicators for ACRV? Use the world's #1 platform.
Open ACRV on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $2
| Metric |
ACRV +3.89% |
GERN -14.10% |
RXT -2.06% |
KAR -1.21% |
|---|---|---|---|---|
| Price | $1.56 | $1.68 | $1.43 | $1.64 |
| Mkt Cap | $0.05B | $1.06B | $0.35B | $1.17B |
| - | View → | View → | View → |
Latest Headlines
Acrivon CEO joins TD Cowen Boston health care fireside chat
Stock Titan • Feb 24, 2026
Top cancer doctors dissect new endometrial trial data in Feb. 27 webcast
Stock Titan • Feb 23, 2026
Acrivon Therapeutics stock plunges after mixed cancer trial results
Investing.com • Jan 8, 2026
Insider Purchase: President and CEO of $ACRV Buys 49,000 Shares | ACRV Stock News
Quiver Quantitative • Jan 16, 2026
H.C. Wainwright Initiates Coverage on Acrivon Therapeutics (ACRV) With “Buy” Rating and $19 PT
Yahoo Finance • Nov 28, 2025
● Gemini Agentic AI Analyst Insight for ACRV
Market Education
- That suit said read and analyze Market trends. How ? Jul 18, 2023
- Large Cap at Lowest Price Apr 9, 2024
- Fails to Deliver DeMystified May 31, 2024
External Research